Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenolic Complex k110-42 Therapy on Cognitive Functions of Children With Down Syndrome
NCT07284693Phase 3Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Neumentix in Down syndrome, sponsored by Mansoura University. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Neumentix
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT07284693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07284693.